Aurevia
Aurevia offers consulting services within medtech regulatory compliance, as well as clinical research CRO services supporting pharmaceuticals, ATMPs, biologics, medical devices, and in vitro diagnostic (IVD) devices. In addition, Aurevia’s External Quality Assessment Services (EQAS) ensure that clinical laboratories meet the required quality standards. The company was formed in 2025 when Scandinavian CRO, QAdvis, Artimed, Clinical Consulting, Kasve, Labquality, and P.R.I.S.M.A. CRO merged to become Aurevia.
Our services for the healthcare, pharmaceutical, and medical technology sectors cover external quality assessments, quality assurance, regulatory affairs, clinical studies, audits and certifications, and training. Our proven expertise and knowledge benefit medical device and IVD manufacturers, pharmaceutical companies, healthcare units, and clinical laboratories around the world.